Long‐term outcome in patients with juvenile idiopathic arthritis

K Minden, M Niewerth, J Listing… - Arthritis & …, 2002 - Wiley Online Library
Objective To describe the long‐term outcome of juvenile idiopathic arthritis (JIA). Methods All
patients with JIA referred to a pediatric rheumatology center between 1978 and 1988 were …

Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy.

…, U Kiessling, J Listing, M Niewerth… - The Journal of …, 2000 - europepmc.org
Objective Evaluation of the course and the prognosis of juvenile chronic arthritis (JCA) and
juvenile spondyloarthropathy (JSpA). Methods The entire medical histories of 171 patients …

Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO

K Minden, M Niewerth, A Zink, E Seipelt… - …, 2012 - academic.oup.com
Objective. To assess the outcome of adult patients with JIA who received etanercept (ETA)
during childhood. Methods. JuMBO (Juvenile arthritis MTX/Biologics long-term Observation) …

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

J Klotsche, M Niewerth, JP Haas, HI Huppertz… - Annals of the …, 2016 - ard.bmj.com
Importance Published evidence on the long-term safety of etanercept (ETA) and adalimumab
(ADA) in patients with polyarticular juvenile idiopathic arthritis (pJIA) is still limited. …

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German …

C Sengler, J Klotsche, M Niewerth, I Liedmann… - RMD open, 2015 - rmdopen.bmj.com
Objective To describe the disease characteristics of patients with juvenile idiopathic arthritis
(JIA) included in an inception cohort, to analyse how many patients from each JIA category …

[PDF][PDF] Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology …

C Tappeiner, S Schenck, M Niewerth… - Arthritis care & …, 2016 - Wiley Online Library
Objective Based on a nationwide database, this study analyzed the influence of methotrexate
(MTX), tumor necrosis factor (TNF) inhibitors, and a combination of the 2 medications on …

[PDF][PDF] Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile …

…, J Klotsche, C Sengler, M Niewerth… - Arthritis & …, 2018 - Wiley Online Library
Objective To analyze the prognostic value of demographic, clinical, and therapeutic factors
and laboratory biomarkers and to assess their role in predicting uveitis occurrence in patients …

Time of Disease‐Modifying antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a Drug‐Free remission in young adulthood

K Minden, G Horneff, M Niewerth… - Arthritis care & …, 2019 - Wiley Online Library
Objective To study juvenile idiopathic arthritis ( JIA ) long‐term outcomes in relation to the
time of initiation of biologic disease‐modifying antirheumatic drug ( bDMARD ). Methods …

Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National …

C Sengler, S Eulert, K Minden, M Niewerth… - RMD open, 2021 - rmdopen.bmj.com
Objectives This study aimed to investigate the clinical manifestations, course and outcome
of SARS-CoV-2 infection among children and adolescents with rheumatic and …

[HTML][HTML] First-year follow-up of children with chronic nonbacterial osteomyelitis—an analysis of the German National Pediatric Rheumatologic Database from 2009 to …

…, M Hufnagel, N Grösch, M Niewerth… - Arthritis Research & …, 2021 - Springer
Objective To assess the first-year features of patients with chronic nonbacterial osteomyelitis
(CNO). Methods Patients with a diagnosis of CNO, disease duration of under 13 months, …